Medindia

X

IntraLinks Poll: Three-Quarters of Life Sciences Executives Say Licensing and Alliance Activity Will Increase In Next 12-24 Months

Tuesday, September 16, 2008 General News J E 4
Advertisement
NEW YORK, Sept. 16 Three-quarters of pharmaceutical, life sciences and healthcare industry executives (74.3 percent) polled during a recent IntraLinks(R) webcast expect licensing and alliance activity at their companies will increase in the next one or two years.



Despite expectations for growth, respondents indicated their greatest concerns for alliance management are operational challenges (31 percent), lack of alignment (31 percent), poor communication (21.7 percent), and lack of visibility into relevant data (11.4 percent).



The most common form of alliance partnerships within respondents' organizations were licensing partnerships (44.1 percent) and strategic alliances (35.5 percent). Far less common alliance partnership forms were acquisitions (6.4 percent) and joint ventures (3.2 percent).



"Two years ago, ROXRO Pharma, Inc. began using IntraLinks' On-Demand Workspaces to help organize data and allow potential partners to review certain information. It cut down on travel time and costs for all parties involved and has since enabled much smoother partnership diligence than ever before," said Gayle Mills, executive vice president of business operations for ROXRO Pharma, Inc.



Other life sciences companies who manage their alliance partnerships through IntraLinks' online workspaces benefit from:



More than 70 executives from the pharmaceutical, life sciences and healthcare industries responded to poll questions during a webcast on July 31, 2008 titled "A Better Way to Conduct Alliance Management."



To view an archived version of this webcast, visit http://www.intralinks.com/webcast-alliance.



About IntraLinks

IntraLinks(R) On-Demand Workspaces(TM) connect business communities and accelerate the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication and fostering rapid workflow.



IntraLinks is easily accessible anywhere, anytime using a web browser. Since 1997, more than 700,000 participants representing over 80,000 organizations worldwide have used IntraLinks On-Demand Workspaces(TM) to communicate and collaborate on thousands of projects and transactions. IntraLinks has been adopted widely in the financial services and pharmaceutical industries, where its clients include AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank, FDIC, TD Securities, Thomas Weisel Partners and WestLB, among hundreds of others. Founded in 1996, IntraLinks is headquartered in New York with offices around the world. For more information, visit www.intralinks.com.



-- Secure central access to all regulatory and clinical data, intellectual property, and product information prior to a partnership event; -- Control at document level by group for review by potential alliance partners; and, -- Relevant, real-time reporting on intelligence around in-licensor activity to help gauge viewer activity and interest.

SOURCE IntraLinks
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Advanced Life Sciences to Present at 2008 UBS Glob...
S
InNexus Lead Candidate DXL625 Outperforms Rituxan ...